Salt Lake City, United States
Recursion, a clinical-stage TechBio company established in 2013, is pioneering advancements in biology with its mission to decode biology to radically improve lives. The company, traded on NASDAQ under the ticker RXRX, operates at the intersection of AI, Biotechnology, Health and Wellness, Pharmaceutical, and Machine Learning.
The cornerstone of Recursion is the Recursion OS, an innovative platform that supports the company’s mission through a massive proprietary dataset encompassing biology and chemistry. Leveraging cutting-edge machine learning and AI, Recursion executes millions of experiments weekly and processes data via one of the world’s most powerful supercomputers, positioning itself as a frontrunner in shaping the future of medicine.
Headquartered in the United States and a founding member of BioHive in Salt Lake City, Recursion operates additional offices in Montréal, New York, London, and Oxford. Its most recent funding event was a post-IPO equity investment from Ark Invest on 01 December 2025.
Biosynth
Octant